Sarah Jendza, PT | |
2520 Main St, Glastonbury, CT 06033-4250 | |
(860) 430-8383 | |
(860) 856-6945 |
Full Name | Sarah Jendza |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 11 Years |
Location | 2520 Main St, Glastonbury, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104299395 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 10723 (Connecticut) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ivyrehab Connecticut Inc | 8325203649 | 49 |
News Archive
Occasional erratic heart rhythms appear to cause about one-fifth of strokes for which a cause is not readily established, according to research presented at the American Stroke Association's International Stroke Conference 2012.
Children conceived by in vitro fertilization (IVF) perform at least as well as their peers on academic tests at all ages from grade 3 to 12, according to a new University of Iowa study.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
Today's younger generation may reckon that "ne'er the twain shall meet" where technology and their elders are concerned. However, ongoing research by Abby King, PhD, professor of health research and policy and of medicine at the Stanford Prevention Research Center, appears to be gradually dispelling that notion.
› Verified 8 days ago
Provider Name | Prohealth Physicians Pc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1720194053 PECOS PAC ID: 1355246950 Enrollment ID: O20031205000602 |
News Archive
Occasional erratic heart rhythms appear to cause about one-fifth of strokes for which a cause is not readily established, according to research presented at the American Stroke Association's International Stroke Conference 2012.
Children conceived by in vitro fertilization (IVF) perform at least as well as their peers on academic tests at all ages from grade 3 to 12, according to a new University of Iowa study.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
Today's younger generation may reckon that "ne'er the twain shall meet" where technology and their elders are concerned. However, ongoing research by Abby King, PhD, professor of health research and policy and of medicine at the Stanford Prevention Research Center, appears to be gradually dispelling that notion.
› Verified 8 days ago
Provider Name | Ivyrehab Connecticut Inc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1265799365 PECOS PAC ID: 8325203649 Enrollment ID: O20120711000223 |
News Archive
Occasional erratic heart rhythms appear to cause about one-fifth of strokes for which a cause is not readily established, according to research presented at the American Stroke Association's International Stroke Conference 2012.
Children conceived by in vitro fertilization (IVF) perform at least as well as their peers on academic tests at all ages from grade 3 to 12, according to a new University of Iowa study.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
Today's younger generation may reckon that "ne'er the twain shall meet" where technology and their elders are concerned. However, ongoing research by Abby King, PhD, professor of health research and policy and of medicine at the Stanford Prevention Research Center, appears to be gradually dispelling that notion.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Sarah Jendza, PT 1311 Mamaroneck Ave Ste 140, White Plains, NY 10605-5224 Ph: (142) 944-0509 | Sarah Jendza, PT 2520 Main St, Glastonbury, CT 06033-4250 Ph: (860) 430-8383 |
News Archive
Occasional erratic heart rhythms appear to cause about one-fifth of strokes for which a cause is not readily established, according to research presented at the American Stroke Association's International Stroke Conference 2012.
Children conceived by in vitro fertilization (IVF) perform at least as well as their peers on academic tests at all ages from grade 3 to 12, according to a new University of Iowa study.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
Today's younger generation may reckon that "ne'er the twain shall meet" where technology and their elders are concerned. However, ongoing research by Abby King, PhD, professor of health research and policy and of medicine at the Stanford Prevention Research Center, appears to be gradually dispelling that notion.
› Verified 8 days ago
Naomi Mazur, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 345 Western Blvd, Glastonbury, CT 06033 Phone: 860-549-8975 | |
Dr. Elizabeth Richter Twombly, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 72 Salmon Brook Dr, Glastonbury, CT 06033 Phone: 860-633-5244 | |
Brian R Wally, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2520 Main St Ste 2, Glastonbury, CT 06033 Phone: 860-430-8383 Fax: 860-856-6945 | |
Jareth Cardoso, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2928 Main St Ste 2, 200, Glastonbury, CT 06033 Phone: 860-430-2344 Fax: 860-430-2349 | |
Rebecca Ferlazzo, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 Hebron Ave Ste 1d, Glastonbury, CT 06033 Phone: 860-781-6999 | |
Sally A Burgess, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2345 Main St, Glastonbury, CT 06033 Phone: 800-998-0880 |